Ownership

Akshay Vaishnaw - Insider Trading & Ownership

Entity: Individual
Location: 300 Third Street, Cambridge, MA
Summary: The estimated net worth of Akshay Vaishnaw is at least $4.52M dollars as of July 1, 2024. Akshay Vaishnaw is the President of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $4.32M. Akshay Vaishnaw is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $206K.
All Insider Reports: All Insider Reports

Ownership of Akshay Vaishnaw

Symbol	Company	Relationship	Holdings Value	Report Period
ALNY	ALNYLAM PHARMACEUTICALS, INC.	President	$4.32M	Aug 3, 2023
SRRK	Scholar Rock Holding Corp	Director	$206K	Jun 27, 2024
EDIT	Editas Medicine, Inc.	Director		May 30, 2024

Showing 1 to 3 of 3 entries

Insider Transactions Reported by Akshay Vaishnaw:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
SRRK	Scholar Rock Holding Corp	Common Stock	Award	+142.8%	$0	0.00	+13.5K	23K	6/27/2024	Direct
SRRK	Scholar Rock Holding Corp	Stock Option (Right to Buy)	Award		$0	0.00	+18K	18K	6/27/2024	Direct
EDIT	Editas Medicine, Inc.	Stock Option (right to buy)	Award		$0	0.00	+25K	25K	5/30/2024	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Sale	-15.1%	-$754K	185.85	-4.06K	22.8K	8/4/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Award	+50%	$0	0.00	+8.94K	26.8K	8/3/2023	Direct
SRRK	Scholar Rock Holding Corp	Stock Option (Right to Buy)	Award		$0	0.00	+36K	36K	6/21/2023	Direct
EDIT	Editas Medicine, Inc.	Stock Option (right to buy)	Award		$0	0.00	+25K	25K	6/1/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Sale	-11.8%	-$465K	194.59	-2.39K	17.9K	4/27/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Award	+35.5%	$0	0.00	+5.31K	20.3K	4/26/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+12K	12K	2/27/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Restricted Stock Units	Award		$0	0.00	+5.79K	5.79K	2/27/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Sale	-71.8%	-$8.22M	215.97	-38K	15K	2/10/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Options Exercise	+139.9%	$1.95M	63.00	+30.9K	53K	2/10/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Options Exercise	-100%	$0	0.00^*	-30.9K	0	2/10/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Tax liability	-5.65%	-$299K	226.20	-1.32K	22.1K	12/5/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Options Exercise	+14.8%	$200K	73.76	+2.71K	21.1K	12/5/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Options Exercise	+11.3%	$100K	42.22^*	+2.37K	23.4K	12/5/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Options Exercise	-8.58%	$0	0.00	-2.71K	28.9K	12/5/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Options Exercise	-100%	$0	0.00^*	-2.37K	0	12/5/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Tax liability	-24.8%	-$1.16M	191.73	-6.05K	18.3K	8/4/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Award	+117.6%	$0	0.00	+13.2K	24.4K	8/3/2022	Direct
SRRK	Scholar Rock Holding Corp	Stock Option (Right to Buy)	Award		$0	0.00	+14K	14K	6/16/2022	Direct
EDIT	Editas Medicine, Inc.	Stock Option (right to buy)	Award		$0	0.00	+25K	25K	6/9/2022	Direct
SRRK	Scholar Rock Holding Corp	Stock Option (Right to Buy)	Award		$0	0.00	+28K	28K	5/26/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+29.8K	29.8K	2/23/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+22.4K	22.4K	12/31/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Sale	-20.4%	-$550K	190.93	-2.88K	11.2K	12/23/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Tax liability	-15.3%	-$480K	189.00	-2.54K	14.1K	12/22/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Award	+48.3%	$0	0.00	+5.42K	16.6K	12/21/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Sale	-49.1%	-$2.17M	200.00	-10.8K	11.2K	8/9/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Options Exercise	+96.6%	$683K	63.00	+10.8K	22K	8/9/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Performance Stock Option 2013 (right to buy)	Options Exercise	-50%	$0	0.00	-10.8K	10.8K	8/9/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Sale	-56.7%	-$2.57M	175.00	-14.7K	11.2K	6/18/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Options Exercise	+76.7%	$683K	63.00	+10.8K	25K	6/18/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Options Exercise	+3.89%	$41K	42.22^*	+970	25.9K	6/18/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Options Exercise	-29.1%	$0	0.00	-970	2.37K	6/18/2021	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Performance Stock Option 2013 (right to buy)	Options Exercise	-33.3%	$0	0.00	-10.8K	21.7K	6/18/2021	Direct
EDIT	Editas Medicine, Inc.	Stock Option (right to buy)	Award		$0	0.00	+11.5K	11.5K	6/3/2021	Direct
SRRK	Scholar Rock Holding Corp	Stock Option (Right to Buy)	Award		$0	0.00	+7.8K	7.8K	5/27/2021	Direct

Previous1Next

Showing 1 to 39 of 39 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.